Mark Wood
About Mark Wood
Mark Wood is a Principle Scientist at Alkermes in Waltham, MA, with over 30 years of experience in pharmacology and oncology.
Company
Mark Wood is currently working at Alkermes as a Principle Scientist. Alkermes is located in Waltham, MA, and is known for its work in the field of biopharmaceuticals.
Title
Mark Wood holds the title of Principle Scientist at Alkermes. In this role, he has been leading oncology and pharmacology research projects since June 2019.
Education and Expertise
Mark Wood has a Ph.D. in Biology from the University of Massachusetts, Amherst. He also holds a B.S. in Biology from Boston College. He combines his educational qualifications with over 30 years of experience in pharmacology and oncology.
Professional Background and Experience
Mark Wood has a long history of working in both academic and industry settings. He served as Senior Research Scientist - Pharmacology at Vertex Pharmaceuticals for 14 years. Prior to that, he was a Research Fellow at Boston Children's Hospital for 2 years. He also worked at OXiGENE, Inc. as an Associate Director for 4 years, Introgen Therapeutics, Inc. as a Research Scientist for 3 years, and Houston Biotechnology for 2 years. His earlier experience includes a 3-year tenure as a Postdoctoral Fellow at The University of Texas Health Science Center at Houston.
Achievements and Contributions
Mark Wood has a strong background in pharmacology, having significantly contributed to oncology research projects during his tenure at multiple companies. His experience includes senior research positions where he played a pivotal role in advancing pharmacological studies and developing innovative treatments.